Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial Publisher Pubmed



Honarvar NM¹ ; Soveid N¹ ; Abdolahi M¹ ; Djalali M¹ ; Hatami M¹ ; Karzar NH²
Source: Endocrine# Metabolic and Immune Disorders - Drug Targets Published:2021

Abstract

Background and Objectives: Migraine is an exhausting neuro-inflammatory disorder recognized as recurrent headache attacks. Evidence has shown that Interleukin (IL)-1β plays a substantial role in the neuro-immunity pathogenicity of migraine. n-3 fatty acids and curcumin revealed neuromodulatory and anti-inflammatory effects through several pathways, of which the suppression of IL-1β gene expression is an important inflammatory pathway. The aim of this study was the investigation of synergistic relation of n-3 fatty acids and nano-curcumin on IL-1β gene expression and serum levels in migraine patients. Methods: This study was performed as a randomized, double-blind, placebo-controlled trial in a period of two months. A total of 80 episodic migraines were assigned into 4 groups of 1) n-3 fatty acids and curcumin combination; 2) n-3 fatty acids; 3) nano-curcumin; and 4) n-3 fatty acids and curcumin placebo. The gene expression and serum level of IL-1β were measured by real-time PCR and ELISA methods respectively, at the beginning and the end of the interventions. Results: Results showed the n-3 fatty acids and nano-curcumin combination significantly reduced the attack frequency in a synergistic status (P < 0.001). A significantly greater reduction in the serum level of IL-1β was observed in the combination group, and the differences in the other groups were not statistically significant. The IL-1β gene expression in the combination group showed a significant reduction for other treatment groups (P < 0.05), but these significant differences were absent after multiple testing Bonferroni corrections. Conclusion: Present findings revealed that n-3 fatty acids and curcumin co-supplementation can be suggested as a promising new approach in migraine headache management, but further studies are needed to confirm these findings. © 2021 Bentham Science Publishers.